BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37566044)

  • 1. PP2A-Mediated GSK3β Dephosphorylation Is Required for Protocadherin-7-Dependent Regulation of Small GTPase RhoA in Osteoclasts.
    Kim H; Takegahara N; Choi Y
    Cells; 2023 Jul; 12(15):. PubMed ID: 37566044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocadherin-7 Regulates Osteoclast Differentiation through Intracellular SET-Binding Domain-Mediated RhoA and Rac1 Activation.
    Kim H; Takegahara N; Choi Y
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocadherin-7 contributes to maintenance of bone homeostasis through regulation of osteoclast multinucleation.
    Kim H; Takegahara N; Walsh MC; Ueda J; Fujihara Y; Ikawa M; Choi Y
    BMB Rep; 2020 Sep; 53(9):472-477. PubMed ID: 32635982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic hnRNPK interacts with GSK3β and is essential for the osteoclast differentiation.
    Fan X; Xiong H; Wei J; Gao X; Feng Y; Liu X; Zhang G; He QY; Xu J; Liu L
    Sci Rep; 2015 Dec; 5():17732. PubMed ID: 26638989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
    Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
    J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death.
    Chen G; Bower KA; Ma C; Fang S; Thiele CJ; Luo J
    FASEB J; 2004 Jul; 18(10):1162-4. PubMed ID: 15132987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontin.
    Mitra A; Menezes ME; Pannell LK; Mulekar MS; Honkanen RE; Shevde LA; Samant RS
    Oncogene; 2012 Oct; 31(41):4472-83. PubMed ID: 22266849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NDRG2 Sensitizes Myeloid Leukemia to Arsenic Trioxide via GSK3β-NDRG2-PP2A Complex Formation.
    Park S; Han HT; Oh SS; Kim DH; Jeong JW; Lee KW; Kim M; Lim JS; Cho YY; Hwangbo C; Yoo J; Kim KD
    Cells; 2019 May; 8(5):. PubMed ID: 31121982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global epigenomic analysis indicates protocadherin-7 activates osteoclastogenesis by promoting cell-cell fusion.
    Nakamura H; Nakashima T; Hayashi M; Izawa N; Yasui T; Aburatani H; Tanaka S; Takayanagi H
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):305-11. PubMed ID: 25446128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption.
    Wang L; Guo X; Zhou W; Ding Y; Shi J; Wu X; Liu Y; Xu Y; Yang H; Geng D
    Acta Biomater; 2018 Jun; 73():488-499. PubMed ID: 29656074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of glycogen synthase kinase-3β is required for osteoclast differentiation.
    Jang HD; Shin JH; Park DR; Hong JH; Yoon K; Ko R; Ko CY; Kim HS; Jeong D; Kim N; Lee SY
    J Biol Chem; 2011 Nov; 286(45):39043-50. PubMed ID: 21949120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade.
    Moon JB; Kim JH; Kim K; Youn BU; Ko A; Lee SY; Kim N
    J Immunol; 2012 Jan; 188(1):163-9. PubMed ID: 22131333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle-dependent palmitoylation of protocadherin 7 by ZDHHC5 promotes successful cytokinesis.
    Ozkan NE; Yigit BN; Degirmenci BS; Qureshi MH; Yapici GN; Kamacıoglu A; Bavili N; Kiraz A; Ozlu N
    J Cell Sci; 2023 Mar; 136(6):. PubMed ID: 36762613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAR2-dependent activation of GSK3β regulates the survival of colon stem/progenitor cells.
    Nasri I; Bonnet D; Zwarycz B; d'Aldebert E; Khou S; Mezghani-Jarraya R; Quaranta M; Rolland C; Bonnart C; Mas E; Ferrand A; Cenac N; Magness S; Van Landeghem L; Vergnolle N; Racaud-Sultan C
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G221-36. PubMed ID: 27313176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
    Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
    Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial Infarction by Activating β-Arrestin-2, Protein Phosphatase 2A, and Glycogen Synthase Kinase-3 and Inhibiting β-Catenin.
    Eid RA; Khalil MA; Alkhateeb MA; Eleawa SM; Zaki MSA; El-Kott AF; Al-Shraim M; El-Sayed F; Eldeen MA; Bin-Meferij MM; Awaji KME; Shatoor AS
    Cardiovasc Drugs Ther; 2021 Dec; 35(6):1095-1110. PubMed ID: 32474680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
    Nicolia V; Fuso A; Cavallaro RA; Di Luzio A; Scarpa S
    J Alzheimers Dis; 2010; 19(3):895-907. PubMed ID: 20157245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner.
    Chu D; Tan J; Xie S; Jin N; Yin X; Gong CX; Iqbal K; Liu F
    J Alzheimers Dis; 2016; 49(2):365-75. PubMed ID: 26484916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis.
    Zhou X; Updegraff BL; Guo Y; Peyton M; Girard L; Larsen JE; Xie XJ; Zhou Y; Hwang TH; Xie Y; Rodriguez-Canales J; Villalobos P; Behrens C; Wistuba II; Minna JD; O'Donnell KA
    Cancer Res; 2017 Jan; 77(1):187-197. PubMed ID: 27821484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.